To evaluate the safety and efficacy of cefdinir oral suspension in children between 6 months and 4 years of age, with acute otitis media, who are at risk of persistent or recurrent otitis media.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
447
cefdinir oral suspension, 25 mg/kg once daily for 10 days
Unnamed facility
Scottsdale, Arizona, United States
Unnamed facility
Clovis, California, United States
Bacteriological Response
Time frame: 30 days
Clinical response
Time frame: 30 days
Change in the otoscopic findings
Time frame: 30 days
Physical exam; Vital signs; Use of concomitant medications
Time frame: 59 days
Adverse events assessment
Time frame: 45 days with follow-up to a satisfactory conclusion
Laboratory evaluations
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Dinuba, California, United States
Unnamed facility
Folsom, California, United States
Unnamed facility
Denver, Colorado, United States
Unnamed facility
Brooklyn, New York, United States
Unnamed facility
Rochester, New York, United States
Unnamed facility
Rochester, New York, United States
Unnamed facility
Chapel Hill, North Carolina, United States
Unnamed facility
Erie, Pennsylvania, United States
...and 12 more locations